Live Price
Live Volume
ImmunityBio Market Segments
Overnight
| Open | $10.58 |
|---|---|
| Close | $10.49 |
| Low | $10.49 |
| Low Change | -0.09 (-0.85%) |
| High | $10.58 |
| High Change | +0.00 (+0.00%) |
| Range | $0.09 |
| Volume | 3.747K |
| Dollar Volume | $39.31K |
After Hours
*No Trades in Segment
Regular Trading Hours
*No Trades in Segment
Premarket
*No Trades in Segment
After Hours Yesterday
| Open | $10.51 |
|---|---|
| Close | $10.60 |
| Low | $10.47 |
| Low Change | -0.04 (-0.38%) |
| High | $10.60 |
| High Change | +0.09 (+0.86%) |
| Range | $0.13 |
| Volume | 1.209M |
| Dollar Volume | $12.81M |
Regular Trading Hours Yesterday
| Open | $9.95 |
|---|---|
| Close | $10.51 |
| Low | $9.87 |
| Low Change | -0.08 (-0.80%) |
| High | $10.80 |
| High Change | +0.85 (+8.54%) |
| Range | $0.93 |
| Volume | 17.363M |
| Dollar Volume | $182.40M |
Premarket Yesterday
| Open | $10.02 |
|---|---|
| Close | $9.97 |
| Low | $9.94 |
| Low Change | -0.09 (-0.85%) |
| High | $10.04 |
| High Change | +0.02 (+0.20%) |
| Range | $0.11 |
| Volume | 82.522K |
| Dollar Volume | $822.74K |
ImmunityBio News
2 months agoinvesting.comImmunityBio stock jumps on UAE drug approval for ANKTIVA
- 5 months agoinvesting.com
ImmunityBio stock gains on five new U.S. patent awards
5 months agobenzinga.comWhy ImmunityBio Stock Is Surging On Wednesday?
- 6 months agoinvesting.com
ImmunityBio stock rises after FDA compliance response
- 7 months agoinvesting.com
ImmunityBio stock surges on $100M financing deal
- 7 months agoinvesting.com
ImmunityBio shares plunge after FDA warning over misleading ads
- 7 months agoinvesting.com
ImmunityBio stock tumbles after FDA warning on misleading ads
- 8 months agoinvesting.com
ImmunityBio stock soars after EU authorization for bladder cancer therapy
- 8 months agoinvesting.com
ImmunityBio stock rises after productive regulatory talks with Saudi FDA
- 9 months agoinvesting.com
ImmunityBio stock soars after FDA meeting on bladder cancer treatment
ImmunityBio Top Trades
We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.
ImmunityBio Moving Averages
| 5 Day Moving Average (SMA5) | $10.06 |
|---|---|
| 10 Day Moving Average (SMA10) | $9.66 |
| 20 Day Moving Average (SMA20) | $9.07 |
| 50 Day Moving Average (SMA50) | $8.30 |
| 100 Day Moving Average (SMA100) | $7.99 |
| 200 Day Moving Average (SMA200) | $7.40 |
ImmunityBio Statistics
| Average Volume (30 Days) | 12.06M |
|---|---|
| P/E Ratio (Current) | -10.54 |
| EPS (Current) | -$0.94 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$288.07M |
| Cash Ratio | 0.99 |
| Current Ratio | 5.72 |
| Quick Ratio | 5.70 |
| Debt to Equity | -0.40 |
| Enterprise Value | $10.84B |
| EV to EBITDA | -46.10 |
| EV to Sales | 65.40 |
| Price to Book | -10.04 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 63.35 |
| Return on Assets | -1.58% |
| Return on Equity | 0.95% |
ImmunityBio Stock Splits
There have been no stock splits for ImmunityBio (IBRX).
ImmunityBio Dividends
There have been no dividends for ImmunityBio (IBRX).